The bottom line...."Although the use of CP seemed

The bottom line...."Although the use of CP seemed to improve resolution of shortness of breath and fatigue, reduce FiO2 requirement in the first week and led to higher negative conversion of viral RNA, this did not translate into reduction in 28-day mortality or progression to severe disease in moderate
COVID-19 patients."